SLC2A1 and neoplasm: GLUT1 was essential for the maintenance of CSCs from different tumor types. A GLUT1 inhibitor inhibited self-renewal, tumor-initiating capacity of CSCs, and delayed tumor initiation after in vivo implantation of CSCs.